The impact of smoking status on one-year secukinumab retention rate in 1,684 patients with psoriatic arthritis: real-world results from the EuroSpA collaboration
04/09/2024
Z. Faizy Ahmadzay1,2, S. Georgiadis3, M. Pons4, M. Lund Hetland5,6, B. Glintborg6,7, S. Møller-Bisgaard8,9, J. Heberg4, S. Nysom Christiansen8, S. Horskjær Rasmussen8, A. G. Loft10,11, I. Castrejon12,13, L. Otero-Varela14, J. Zavada15,16, K. Pavelka15,16, H. Relas17, L. Kuusalo18, B. Moeller19, M. J. Nissen20, Z. Rotar21,22, K. Perdan Pirkmajer22,23, D. Santos Oliveira24, A. R. Cruz-Machado25,26,27, B. Michelsen28,29,30, E. Kristianslund28, B. Gudbjornsson31,32, G. Grondal32,33, K. Laas34, P. He
EULAR 2024
DOI: 10.1136/annrheumdis-2024-eular.344
https://ard.bmj.com/content/83/Suppl_1/679.2